Skip to main content
Business Of Biotech

An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.

58 min episode · 2 min read
·
Bunka's Monika Sumra,An Anthropological Lens

Episode

58 min

Read time

2 min

Topics

Career Growth, Productivity, Health & Wellness

AI-Generated Summary

Key Takeaways

  • Cultural Performance Indicators (CPIs): Bunka developed CPIs to measure upstream human conditions — trust flow, decision latency, belief alignment, and follow-through — that predict future performance before it appears in KPIs. Where KPIs report what already happened, CPIs reveal what is forming now, giving leadership a forward-looking window into organizational health.
  • Environment over individual: Leadership struggles are rarely capability failures. When talented leaders check out or leave, the environment is typically the cause. Before addressing individual performance, map how decisions actually get made, where information stalls, and where people feel unsafe speaking up — these structural conditions determine whether leadership can function at all.
  • Culture cannot be changed directly: Culture is an emergent property, not a fixed object. Attempting to change it directly fails. Instead, change the conditions shaping beliefs and behavior — hiring practices, process design, incentive structures — and culture shifts as a consequence. Sumra uses the analogy of Jell-O: culture must retain flex, not be treated as permanent.
  • AI as environment magnifier: Before deploying AI tools in life sciences operations, audit whether people feel safe sharing uncertainty, whether judgment carries real authority, and whether incentives align with stated goals. AI amplifies existing patterns — both functional and dysfunctional — at accelerated speed, so misaligned environments produce compounded misalignment, not efficiency gains.
  • Human error is pattern, not randomness: Designing error out of manufacturing processes requires treating human mistakes as predictable system outputs, not individual failures. The replacement behavior must be easier than the original behavior — adding procedural steps increases cognitive load and drives workarounds. Permanent fixes address the conditions producing the error, not the person who made it.

What It Covers

Monika Sumra, PhD, founder of Bunka Incorporated, applies biosocial anthropology to life sciences organizations, explaining how environment shapes leadership and performance. She introduces Cultural Performance Indicators (CPIs) as measurable tools that reveal the human conditions driving future results in biotech and pharma manufacturing.

Key Questions Answered

  • Cultural Performance Indicators (CPIs): Bunka developed CPIs to measure upstream human conditions — trust flow, decision latency, belief alignment, and follow-through — that predict future performance before it appears in KPIs. Where KPIs report what already happened, CPIs reveal what is forming now, giving leadership a forward-looking window into organizational health.
  • Environment over individual: Leadership struggles are rarely capability failures. When talented leaders check out or leave, the environment is typically the cause. Before addressing individual performance, map how decisions actually get made, where information stalls, and where people feel unsafe speaking up — these structural conditions determine whether leadership can function at all.
  • Culture cannot be changed directly: Culture is an emergent property, not a fixed object. Attempting to change it directly fails. Instead, change the conditions shaping beliefs and behavior — hiring practices, process design, incentive structures — and culture shifts as a consequence. Sumra uses the analogy of Jell-O: culture must retain flex, not be treated as permanent.
  • AI as environment magnifier: Before deploying AI tools in life sciences operations, audit whether people feel safe sharing uncertainty, whether judgment carries real authority, and whether incentives align with stated goals. AI amplifies existing patterns — both functional and dysfunctional — at accelerated speed, so misaligned environments produce compounded misalignment, not efficiency gains.
  • Human error is pattern, not randomness: Designing error out of manufacturing processes requires treating human mistakes as predictable system outputs, not individual failures. The replacement behavior must be easier than the original behavior — adding procedural steps increases cognitive load and drives workarounds. Permanent fixes address the conditions producing the error, not the person who made it.

Notable Moment

Sumra argues that the concept of the "alpha" leader — borrowed from animal research — does not hold up under scrutiny. Her doctoral research found that behaviors labeled alpha shift entirely based on context, expectations, and what gets rewarded, meaning leadership status is situational and environmentally constructed, not an inherent personal trait.

Know someone who'd find this useful?

Episode Transcript

Welcome back to the Business of Biotech. I'm your host, Ben Comer, chief editor at Life Science Leader. And today, I'm speaking with doctor Monica Sumra, founder and managing partner at Bunker Incorporated, a management consulting firm and advisor to manufacturing based organizations globally. Monica is a published author and speaker with a unique lens built on a PhD in biosocial anthropology. Her work with life sciences organization sits at the intersection of leadership, performance, and environment. By focusing on environment, Bunka helps organizations develop and set the conditions for sustainable leadership, responsibility, and results. I'm pleased to speak with Monica today about how life sciences companies can build better work environments to set themselves up for success, how to bring quantitative analysis to corporate culture, and how the tools of anthropology can be used to drive efficiencies in key functional areas like manufacturing. Monica, thank you so much for being here. It is my pleasure. Thank you so much for for having having me on. I really appreciate it. Yeah. Well, I'm excited to speak with you. I think you bring an interesting perspective that, we haven't heard on the business of biotech, and I I wanna maybe just start there with your background. I mentioned you received a PhD, biosocial anthropology from the University of Toronto. How did you become initially interested in in this field? So very good question. And for me, it's always really been I've already always been interested about how people learning how people actually behave when the stakes are real, not how we sing, we behave, or how we design systems really assuming how people will behave. So these are these are things that are I was always interested in. And so anthropology really gave me a a way to really study humans and context. Right? That's what anthropologists do. And the the great thing about anthropology is that it doesn't separate people from environments. And what we look at as anthropologists in any sort of social context is, you know, how does power, hierarchy, uncertainty, and really meaning, you know, shape behavior over time. And that's really what made me very, very interested in it. And once you start seeing behavior that way, a lot of what we call failure really starts to look more like adaptation, over time. And for me, that's the whole idea of being interested in that was just interesting, actually, by human beings just more generally because I happen to be one. So it it's it's it's just really going deeper and and and really understanding my own ways of thinking, challenging myself, and really becoming that individual who really takes all these different perspectives into consideration, you know, before coming to a conclusion. So that's really what got me interested in it, as I progressed. Have you always been a kind of student of human behavior, or do you you know, was that something, like, even as, you know, as a child or or a young …

Get the full transcript (9,964 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all Business Of Biotech transcripts →

You just read a 3-minute summary of a 55-minute episode.

Get Business Of Biotech summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

More from Business Of Biotech

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best Biotech Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into Business Of Biotech.

Every Monday, we deliver AI summaries of the latest episodes from Business Of Biotech and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime